An evaluation of sirolimus in renal transplantation

Fabian Halleck, Michael Duerr, Johannes Waiser, Lu Huber, Mareen Matz, Susanne Brakemeier, Lutz Liefeldt, Hans Hellmut Neumayer, Klemens Budde

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Introduction: Sirolimus is a powerful antiproliferative immunosuppressive drug approved for the prevention of kidney allograft rejection. By its unique mechanism of action, sirolimus provides a multitude of clinical potential and has been used effectively in different drug combinations. Extensive experience has been gained regarding the best timing of its application, side effect profile and potential benefits and limitations compared with other immunosuppressive drugs. Areas covered: The authors evaluate the recent experience with sirolimus in kidney transplantation. Pivotal randomized controlled trials were used to provide an overview with special attention to pharmacokinetic and dynamic aspects of sirolimus, its current clinical use as well as perspectives for its future role. Expert opinion: Sirolimus enriches the possibilities of immunosuppressive therapies after renal transplantation. Beneficial effects toward kidney function by allowing CNI sparing, lower incidence of malignancies and less viral infections have been suggested. Sirolimus should be used cautiously in de novo patients for reasons of wound healing. An early conversion to a sirolimus-based CNI-free regimen has shown promising results, whereas late conversion is more challenging. Finally, sirolimus-associated side effects are causing tolerability concerns and frequent discontinuations. Future research should aim to better define the therapeutic window and those patients most likely to benefit.

Original languageEnglish (US)
Pages (from-to)1337-1356
Number of pages20
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume8
Issue number10
DOIs
StatePublished - Oct 1 2012

Keywords

  • Calcineurin inhibitors
  • Kidney transplantation
  • MTOR inhibitors
  • Rapamycin
  • Sirolimus

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'An evaluation of sirolimus in renal transplantation'. Together they form a unique fingerprint.

  • Cite this

    Halleck, F., Duerr, M., Waiser, J., Huber, L., Matz, M., Brakemeier, S., Liefeldt, L., Neumayer, H. H., & Budde, K. (2012). An evaluation of sirolimus in renal transplantation. Expert Opinion on Drug Metabolism and Toxicology, 8(10), 1337-1356. https://doi.org/10.1517/17425255.2012.719874